<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39468177</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Latent class analysis of hospitalization, ICU admission, and mortality among COVID-19 patients in Iran.</ArticleTitle><Pagination><StartPage>25770</StartPage><MedlinePgn>25770</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-75712-7</ELocationID><Abstract><AbstractText>Identifying COVID-19 patients' clinical phenotypes based on characteristics and comorbidities, as well as their differences, helps in terms of clinical care and potential crises. Our goal is to use Latent Class Analysis (LCA) to identify COVID-19 patient profiles based on demographics, symptoms, and comorbidities, and evaluate their correlation with ICU admission, hospitalization duration, and mortality in a cross-sectional study. We included hospitalized patients with positive SARS-CoV-2 tests in two referral hospitals in the south of Iran between January 2020 and July 2021. Data from 7,968 patients were evaluated in two time-specific intervals, known as "stratum," based on the point at which the COVID-19 fourth peak and vaccinations were nearly initiated. After applying LCA, three classes identified the most at-risk individuals, including elderly women with hypertension, diabetes, and heart disease, and elderly men with heart and lung conditions, compared to two classes of healthier, younger individuals. Hospital stays were longer in the first stratum compared with the second (P-value = 0.043). ICU admission during the first stratum was significantly higher than in the second stratum (P &lt; 0.001) and lower in classes one and two in the first stratum compared to class three (reference class). Mortality rates were not significantly different between strata (P = 0.054). Hospital stays and mortality rates significantly differed between the classes in each first and second stratum (P &lt; 0.001). Using LCA to investigate COVID-19 patients has provided valuable insights into different patterns and outcomes of the disease. Patient variables, including age, gender, and comorbidities, were associated with greater mortality and ICU admission, which can assist in resource allocation and vaccination planning.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ranjbar</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gastroenterohepatology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of MPH, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bordbar</LastName><ForeName>Mohammad Reza</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Hematology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of MPH, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirhosseini</LastName><ForeName>Seyed Alireza</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of MPH, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghimizadeh</LastName><ForeName>Mohammad Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of MPH, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Education Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lankarani</LastName><ForeName>Kamran Bagheri</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omidifar</LastName><ForeName>Navid</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Departmant of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardanjani</LastName><ForeName>Hossein Molavi</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of MPH, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. molavih@sums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Traditional Medicine and History of Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. molavih@sums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077272" MajorTopicYN="Y">Latent Class Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="Y">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Comorbidities</Keyword><Keyword MajorTopicYN="N">Death</Keyword><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">Latent class analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>0</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39468177</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-75712-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-75712-7</ArticleId></ArticleIdList><ReferenceList><Title /><Reference><Citation>Lenharo, M. WHO declares end to COVID-19’s emergency phase (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-01559-z</ArticleId></ArticleIdList></Reference><Reference><Citation>David, A. et al. (eds) Latent Class Analysis of COVID-19 Deaths by Comorbidities, medRxiv; 2024. United States (2020).</Citation></Reference><Reference><Citation>Wu, Z. &amp; McGoogan, J. M. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 323(13), 1239–1242 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, A. K. et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes. Metab. 22(10), 1915–1924 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14124</ArticleId><ArticleId IdType="pubmed">32573903</ArticleId><ArticleId IdType="pmc">7361304</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng, G., Yin, M., Chen, X. &amp; Zeng, F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit. Care. 24(1), 179 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02902-w</ArticleId><ArticleId IdType="pubmed">32345311</ArticleId><ArticleId IdType="pmc">7187660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X., Jehi, L., Ji, X. &amp; Mazzone, P. J. Phenotypes and subphenotypes of patients with COVID-19: a latent class modeling analysis. Chest. 159(6), 2191–2204 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.01.057</ArticleId><ArticleId IdType="pubmed">33640378</ArticleId></ArticleIdList></Reference><Reference><Citation>McCutcheon A L. Basic concepts and procedures in single-and multiple-group latent class analysis. In: Hagenaars J A, McCutcheon AL, editors. Applied Latent Class Analysis. Cambridge University Press, Cambridge, 56-88. https://doi.org/10.1017/CBO9780511499531.003</Citation></Reference><Reference><Citation>Collins, L. M. &amp; Lanza, S. T. Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. Hoboken, New Jersey. John Wiley &amp; Sons, Inc.; 2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470567333</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanza, S. T. &amp; Rhoades, B. L. Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment. Prev. Sci. 14(2), 157–168 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11121-011-0201-1</ArticleId><ArticleId IdType="pubmed">21318625</ArticleId><ArticleId IdType="pmc">3173585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabetian, G. et al. Prediction of patients with COVID-19 requiring Intensive Care: a cross-sectional study based on machine-learning approach from Iran. Indian J. Crit. Care Med. 26(6), 688–695 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-24226</ArticleId><ArticleId IdType="pubmed">35836646</ArticleId><ArticleId IdType="pmc">9237161</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng, C. et al. Identification of phenotypes among COVID-19 patients in the United States using latent class analysis. Infect. Drug Resist. 14, 3865–3871 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S331907</ArticleId><ArticleId IdType="pubmed">34584430</ArticleId><ArticleId IdType="pmc">8464321</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang, X., Li, X., Bian, Y., Ji, X. &amp; Lu, J. Relationship between clinical types and radiological subgroups defined by latent class analysis in 2019 novel coronavirus pneumonia caused by SARS-CoV-2. Eur. Radiol. 30(11), 6139–6150 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-06973-9</ArticleId><ArticleId IdType="pubmed">32474631</ArticleId><ArticleId IdType="pmc">7261041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha, P. et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with Differential responses to corticosteroids. Am. J. Respir Crit. Care Med. 204(11), 1274–1285 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202105-1302OC</ArticleId><ArticleId IdType="pubmed">34543591</ArticleId><ArticleId IdType="pmc">8786071</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakeri, R. et al. Biological responses to COVID-19: insights from physiological and blood biomarker profiles. Curr. Res. Transl. Med. 69(2), 103276 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33588321</ArticleId><ArticleId IdType="pmc">7857048</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi-Asl, E., Adham, D., Ghobadi, H. &amp; Abbasi-Ghahramanloo, A. Clustering of COVID-19 symptoms among Iranian patients: the role of preexisting comorbidity on latent class membership. Asia Pac. J. Public. Health. 33(5), 651–654 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10105395211017755</ArticleId><ArticleId IdType="pubmed">34018399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseinzadeh, A. et al. Epidemiological patterns of syndromic symptoms in suspected patients with COVID-19 in Iran: a latent class analysis. J. Res. Health Sci. 21(1), e00508 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/jrhs.2021.41</ArticleId><ArticleId IdType="pubmed">34024766</ArticleId><ArticleId IdType="pmc">8957697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatami, H., Saeidi Kiasari, M. R. &amp; Rezapour, M. The evaluation of diagnostic values of clinical symptoms for COVID-19 hospitalized patients in Northern Iran: the syndromic surveillance system data. Arch. Clin. Infect. Dis. 17(1), e117465 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/archcid-117465</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari, M. &amp; Jafari, H. Challenges of COVID-19 vaccination in Iran: in the Fourth Wave of Pandemic Spread. Prehosp. Disaster Med. 36(5), 659–660 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1049023X21000777</ArticleId><ArticleId IdType="pubmed">34287113</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie, H., Roser, M. &amp; Rosado, P. CO2and Greenhouse Gas Emissions OurWorldInData.org (2020). Available from: https://ourworldindata.org/coronavirus/country/iran .</Citation></Reference><Reference><Citation>Weller, B. E., Bowen, N. K. &amp; Faubert, S. J. Latent class analysis: a guide to best practice. J. Black Psychol. 46(4), 287–311 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0095798420930932</ArticleId></ArticleIdList></Reference><Reference><Citation>Nylund-Gibson K, Choi AY. Ten frequently asked questions about latent class analysis. Transl Issues Psychol Sci. 4(4), 440 (2018).</Citation></Reference><Reference><Citation>Gao, Q. et al. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China. Med. (Baltim). 99(23), e20605 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000020605</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshayeshi, L. et al. Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran. BMC Infect. Dis. 21(1), 656 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06363-6</ArticleId><ArticleId IdType="pubmed">34233638</ArticleId><ArticleId IdType="pmc">8261035</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira, R. D. S. COVID-19: intensive care units, mechanical ventilators, and latent mortality profiles associated with case-fatality in Brazil. Cad Saude Publica. 36(5), e00080020 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0102-311x00080020</ArticleId><ArticleId IdType="pubmed">32428072</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez, I. D. et al. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: a multicenter, observational study. Lancet Reg. Health Eur. 18, 100422 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100422</ArticleId><ArticleId IdType="pubmed">35655660</ArticleId><ArticleId IdType="pmc">9148543</ArticleId></ArticleIdList></Reference><Reference><Citation>Child, G. B. D. &amp; Adolescent Communicable Disease, C. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the global burden of Disease Study 2019. Lancet. 402(10398), 313–335 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00860-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi, F. et al. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves. BMC Infect. Dis. 24(1), 55 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08939-w</ArticleId><ArticleId IdType="pubmed">38184533</ArticleId><ArticleId IdType="pmc">10771668</ArticleId></ArticleIdList></Reference><Reference><Citation>Twohig, K. A. et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect. Dis. 22(1), 35–42 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00475-8</ArticleId><ArticleId IdType="pubmed">34461056</ArticleId><ArticleId IdType="pmc">8397301</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>